Clinical Trial Update: The Study of CM326 in Moderate-to-severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CM326 in moderate-to-severe atopic dermatitis is reported with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Moderate-to-severe Atopic Dermatitis

Drugs mentioned

• CM326

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Moderate-to-severe Atopic Dermatitis | Phase 2 | Status: UNKNOWN